These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 869682)

  • 21. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.
    Lee HH; Wilson WR; Ferry DM; van Zijl P; Pullen SM; Denny WA
    J Med Chem; 1996 Jun; 39(13):2508-17. PubMed ID: 8691448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antitumor properties of pyrazolo [3,4-D] pyrimidine derivatives.
    Witkiewicz K; Machoń Z; Mordarski M; Wieczorek J
    Pol J Pharmacol Pharm; 1987; 39(6):715-20. PubMed ID: 3503990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Paramagnetic diethyleneimides of urethane phosphoric acids as antitumor agents].
    Emanuél' NM; Zhdanov RI; Konovalova NP; Vasil'eva LS; Buina NA
    Vopr Onkol; 1980; 26(5):54-8. PubMed ID: 6247836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New water-soluble duocarmycin derivatives: synthesis and antitumor activity of A-ring pyrrole compounds bearing beta-heteroarylacryloyl groups.
    Amishiro N; Nagamura S; Kobayashi E; Gomi K; Saito H
    J Med Chem; 1999 Feb; 42(4):669-76. PubMed ID: 10052974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological and toxicological aspects of new imidazoacridinone antitumor agents.
    Berger B; Marquardt H; Westendorf J
    Cancer Res; 1996 May; 56(9):2094-104. PubMed ID: 8616856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on antitumor and myelotoxic effect of Ledakrin and its selected analogues.
    Glazman-Kuśnierczyk H; Radzikowski C; Budzyński W; Paprocka M
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):385-93. PubMed ID: 6191735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor properties of selected 1,2,4-triazine derivatives.
    Mordarski M; Wieczorek J; Fiszer L; Nantka-Namirski P; Rykowski A
    Arch Immunol Ther Exp (Warsz); 1980; 28(5):717-25. PubMed ID: 7212979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical evaluation of dichlorobis(1-phenylbutane-1,3-dionato)titanium (IV) and budotitane. Two representatives of the new class of antitumor-active bis-beta-diketonato metal complexes.
    Keppler BK; Schmähl D
    Arzneimittelforschung; 1986 Dec; 36(12):1822-8. PubMed ID: 3566844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on vomitory effect of some acridine compounds.
    Kowalczyk-Bronisz SH
    Arch Immunol Ther Exp (Warsz); 1980; 28(5):777-82. PubMed ID: 7212983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on the antitumor active polysaccharides from the mycelia of Poria cocos Wolf. III. Antitumor activity against mouse tumors].
    Kanayama H; Togami M; Adachi N; Fukai Y; Okumoto T
    Yakugaku Zasshi; 1986 Apr; 106(4):307-12. PubMed ID: 3735073
    [No Abstract]   [Full Text] [Related]  

  • 31. Potent antitumor 9-anilinoacridines and acridines bearing an alkylating N-mustard residue on the acridine chromophore: synthesis and biological activity.
    Su TL; Lin YW; Chou TC; Zhang X; Bacherikov VA; Chen CH; Liu LF; Tsai TJ
    J Med Chem; 2006 Jun; 49(12):3710-8. PubMed ID: 16759114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antitumor activity of carminomycin antibiotic used orally].
    Shorin VA; Bazhanov VS; Averbukh LA
    Antibiotiki; 1976 Nov; 21(11):1005-7. PubMed ID: 1037187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity of tetrahydro-2-furanyl- and tetrahydro-2-pyranyl-glucans obtained by chemical modification of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140 and its lower molecular weight glucans.
    Sasaki T; Abiko N; Uchida H; Tanaka M; Nitta K; Yoshioka Y; Nomura H
    Cancer Treat Rep; 1983 Mar; 67(3):275-80. PubMed ID: 6831473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunomodulating and antitumor activity of polysaccharides of plant origin].
    Sergeev AV; Revazova ES; Denisova SI; Kalatskaia OV; Rytenko AN
    Biull Eksp Biol Med; 1985 Dec; 100(12):741-3. PubMed ID: 2934103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression of 180J sarcoma after treatment with substituted indoloquinolinones.
    Tarnowski GS; Stock CC; Grunberg E
    Cancer Treat Rep; 1978 Oct; 62(10):1575-6. PubMed ID: 709558
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental antitumor activity and toxicity of the selected triazolo- and imidazoacridinones.
    Kuśnierczyk H; Chołody WM; Paradziej-Lukowicz J; Radzikowski C; Konopa J
    Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):415-23. PubMed ID: 8572901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor inhibition by titanocene complexes: activity against sarcoma 180.
    Köpf-Maier P; Preiss F; Marx T; Klapötke T; Köpf H
    Anticancer Res; 1986; 6(1):33-7. PubMed ID: 3954328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor effect of 2-thio-4-hydrazinouracil on transplantable tumors.
    Golovinsky EV; Emanuilov EA; Spassovska NC; Spassov AV
    Neoplasma; 1975; 22(3):255-8. PubMed ID: 1161120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C.
    Morimoto M; Ashizawa T; Ohno H; Azuma M; Kobayashi E; Okabe M; Gomi K; Kono M; Saitoh Y; Kanda Y
    Cancer Res; 1991 Jan; 51(1):110-5. PubMed ID: 1988076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity and interleukin-1 induction by tannins.
    Miyamoto K; Murayama T; Nomura M; Hatano T; Yoshida T; Furukawa T; Koshiura R; Okuda T
    Anticancer Res; 1993; 13(1):37-42. PubMed ID: 8476228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.